For csDMARDs, we noted a slight trend towards reduced dispensations that was accentuated during 2020 (−8.5%), a marked drop in treatment starts and an accompanying but less pronounced drop in treatment discontinuation.
← all excerpts
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision.
2
—
—
The sentences
For dispensations and treatment starts, there was an increasing trend of DMARD use for 2015–2019 that did not continue during 2020.